Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.
AnnaLynn M WilliamsAndrea M BaranMahlon SchafferJocelyn BushartLynn RichJeremiah MoorePaul M BarrClive S ZentPublished in: American journal of hematology (2019)